Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

News   Jan 11, 2018 | Original story from National Institutes of Health

 
Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

The round, spiked objects at center are MERS coronavirus particles. Credit: NIAID

 
 
 

RELATED ARTICLES

Boyds Acquires New Cambridge Office to Support Rapid Growth

News

Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.

READ MORE

Anti-Inflammatory Pill Could Make Vaccines More Effective for the Elderly

News

By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

READ MORE

Uniqsis Reports on Expansion

News

Uniqsis reports following excellent business growth in 2017 that it has recruited a further sales / support specialist to be located at its office in Cambridge.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE